Cite
HARVARD Citation
Bressler, B. et al. (n.d.). P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn's disease patients (EVOLVE) in Canada: Interim results. Journal of Crohn's and colitis. p. S382. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bressler, B. et al. (n.d.). P546 Vedolizumab outcomes in real-world bio-naive ulcerative colitis and Crohn's disease patients (EVOLVE) in Canada: Interim results. Journal of Crohn's and colitis. p. S382. [Online].